Paramyxovirus entry

Advances in Experimental Medicine and Biology

Volumn 790, Issue , 2013, Pages 95-127

  Bossart, Katharine N ^a   Fusco, Deborah L ^b   Broder, Christopher C ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUSION GLYCOPROTEIN; HN PROTEIN; PROTEINASE; THROMBOSPONDIN; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ARTICLE; CELL MEMBRANE; CONFORMATIONAL TRANSITION; CRYSTAL STRUCTURE; HOST CELL; MEMBRANE FUSION; NONHUMAN; PARAMYXOVIRUS; PARAMYXOVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN STRUCTURE; PROTEIN TERTIARY STRUCTURE; RECEPTOR BINDING; VIRAL TROPISM; VIRION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS PARTICLE; VIRUS VIRULENCE;

HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HN PROTEIN; HUMANS; PARAMYXOVIRIDAE; PROTEIN CONFORMATION; RECEPTORS, VIRUS; VIRAL FUSION PROTEINS; VIRUS ATTACHMENT; VIRUS INTERNALIZATION;

EID: 84881414330     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-7651-1_6     Document Type: Article

References (197)

1. Lamb RA, Parks GD. Paramyxoviridae: The viruses and their replication. In: Knipe DM, Howley PM eds. Fields Virology, 5 ed. Philadelphia: Lippincott Williams & Wilkins, 2007:1449-1496.
2. Alexander DJ. Newcastle disease and other avian paramyxoviruses. Rev Sci Tech 2000; 19(2):443-462.
3. Tambi EN, Maina OW, Mukhebi AW et al. Economic impact assessment of rinderpest control in Africa. Rev Sci Tech 1999; 18(2):458-477.
4. Eaton BT, Broder CC, Middleton D et al. Hendra and Nipah viruses: different and dangerous. Nat Rev Microbiol 2006; 4(1):23-35.
5. Eaton BT, Mackenzie JS, Wang L-F. Henipaviruses. In: Knipe DM, Howley PM ed. Fields Virology, 5 ed. Philadelphia: Lippincott Williams & Wilkins, 2007:1587-1600.
6. Lamb RA. Mononegavirales. In: Knipe DM, Howley PM ed. Fields Virology, 5 ed. Philadelphia: Lippincott Williams and Wilkins, 2007:1357-1361.
7. Mayo MA. A summary of taxonomic changes recently approved by ICTV. Arch Virol 2002; 147(8):1655-1663.
8. de Leeuw O, Peeters B. Complete nucleotide sequence of Newcastle disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol 1999; 80(Pt 1):131-136.
9. Seal BS, Crawford JM, Sellers HS et al. Nucleotide sequence analysis of the Newcastle disease virus nucleocapsid protein gene and phylogenetic relationships among the Paramyxoviridae. Virus Res 2002; 83(1-2):119-129.
10. Seal BS, King DJ, Meinersmann RJ. Molecular evolution of the Newcastle disease virus matrix protein gene and phylogenetic relationships among the paramyxoviridae. Virus Res 2000; 66(1):1-11.
11. Wang LF, Yu M, Hansson E et al. The exceptionally large genome of Hendra virus: support for creation of a new genus within the family Paramyxoviridae. J Virol 2000; 74(21):9972-9979.
12. Li Z, Yu M, Zhang H et al. Beilong virus, a novel paramyxovirus with the largest genome of non-segmented negative-stranded RNA viruses. Virology 2006; 346(1):219-228.
13. Kurath G, Batts WN, Ahne W et al. Complete genome sequence of Fer-de-Lance virus reveals a novel gene in reptilian paramyxoviruses. J Virol 2004; 78(4):2045-2056.
14. Marsh GA, de Jong C, Barr JA et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog 2012; 8(8):e1002836.
15. Morrison TG. The three faces of paramyxovirus attachment proteins. Trends Microbiol 2001; 9(3):103-105.
16. Lamb RA, Jardetzky TS. Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol 2007; 17(4):427-436.
17. Parks GD, Lamb RA. Folding and oligomerization properties of a soluble and secreted form of the paramyxovirus hemagglutinin-neuraminidase glycoprotein. Virology 1990; 178(2):498-508.
18. Scheid A, Caliguiri LA, Compans RW et al. Isolation of paramyxovirus glycoproteins. Association of both hemagglutinating and neuraminidase activities with the larger SV5 glycoprotein. Virology 1972; 50(3):640-652.
19. Thompson SD, Portner A. Localization of functional sites on the hemagglutinin-neuraminidase glycoprotein of Sendai virus by sequence analysis of antigenic and temperature-sensitive mutants. Virology 1987; 160(1):1-8.
20. Langedijk JP, Daus FJ, van Oirschot JT. Sequence and structure alignment of Paramyxoviridae attachment proteins and discovery of enzymatic activity for a morbillivirus hemagglutinin. J Virol 1997; 71(8):6155-6167.
21. Yu M, Hansson E, Langedijk JP et al. The attachment protein of Hendra virus has high structural similarity but limited primary sequence homology compared with viruses in the genus Paramyxovirus. Virology 1998; 251(2):227-233.
22. Iorio RM, Melanson VR, Mahon PJ. Glycoprotein interactions in paramyxovirus fusion. Future Virol 2009; 4(4):335-351.
23. Colman PM, Hoyne PA, Lawrence MC. Sequence and structure alignment of paramyxovirus hemagglutinin-neuraminidase with influenza virus neuraminidase. J Virol 1993; 67(6):2972-2980.
24. Crennell S, Takimoto T, Portner A et al. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol 2000; 7(11):1068-1074.
25. Lawrence MC, Borg NA, Streltsov VA et al. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol 2004; 335(5):1343-1357.
26. Yuan P, Thompson TB, Wurzburg BA et al. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure (Camb) 2005; 13(5):803-815.
27. Yuan P, Swanson KA, Leser GP et al. Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci USA 2011; 108(36):14920-14925.
28. Hashiguchi T, Kajikawa M, Maita N et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci USA 2007; 104(49):19535-19540.
29. Colf LA, Juo ZS, Garcia KC. Structure of the measles virus hemagglutinin. Nat Struct Mol Biol 2007; 14(12):1227-1228.
30. Bowden TA, Aricescu AR, Gilbert RJ et al. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol 2008; 15(6):567-572.
31. Xu K, Rajashankar KR, Chan YP et al. Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3. Proc Natl Acad Sci USA 2008; 105(29):9953-9958.
32. Thompson SD, Laver WG, Murti KG et al. Isolation of a biologically active soluble form of the hemagglutinin-neuraminidase protein of Sendai virus. J Virol 1988; 62(12):4653-4660.
33. Markwell MA, Fox CF. Protein-protein interactions within paramyxoviruses identified by native disulfide bonding or reversible chemical cross-linking. J Virol 1980; 33(1):152-166.
34. Morrison TG, McQuain C, O'Connell KF et al. Mature, cell-associated HN protein of Newcastle disease virus exists in two forms differentiated by posttranslational modifications. Virus Res 1990; 15(2):113-133.
35. Ng DT, Randall RE, Lamb RA. Intracellular maturation and transport of the SV5 type II glycoprotein hemagglutinin-neuraminidase: specific and transient association with GRP78-BiP in the endoplasmic reticulum and extensive internalization from the cell surface. J Cell Biol 1989; 109(6 Pt 2):3273-3289.
36. Russell R, Paterson RG, Lamb RA. Studies with cross-linking reagents on the oligomeric form of the paramyxovirus fusion protein. Virology 1994; 199(1):160-168.
37. Ng DT, Hiebert SW, Lamb RA. Different roles of individual N-linked oligosaccharide chains in folding, assembly, and transport of the simian virus 5 hemagglutinin-neuraminidase. Mol Cell Biol 1990; 10(5):1989-2001.
38. Zaitsev V, von Itzstein M, Groves D et al. Second sialic acid binding site in Newcastle disease virus hemagglutinin-neuraminidase: implications for fusion. J Virol 2004; 78(7):3733-3741.
39. Plemper RK, Hammond AL, Cattaneo R. Characterization of a region of the measles virus hemagglutinin sufficient for its dimerization. J Virol 2000; 74(14):6485-6493.
40. Brindley MA, Plemper RK. Blue native PAGE and biomolecular complementation reveal a tetrameric or higher-order oligomer organization of the physiological measles virus attachment protein H. J Virol 2010; 84(23):12174-12184.
41. Bossart KN, Crameri G, Dimitrov AS et al. Receptor binding, fusion inhibition and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus. J Virol 2005; 79(11):6690-6702.
42. Maar D, Harmon B, Chu D et al. Cysteines in the stalk of the Nipah virus G glycoprotein are located in a distinct subdomain critical for fusion activation. J Virol 2012; 86(12):6632-6642.
43. Steffen DL, Xu K, Nikolov DB et al. Henipavirus Mediated Membrane Fusion, Virus Entry and Targeted Therapeutics. Viruses 2012; 4(2):280-308.
44. Choppin PW, Scheid A. The role of viral glycoproteins in adsorption, penetration, and pathogenicity of viruses. Rev Infect Dis 1980; 2(1):40-61.
45. Dorig RE, Marcil A, Chopra A et al. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75(2):295-305.
46. Naniche D, Varior-Krishnan G, Cervoni F et al. Human membrane cofactor protein (CD46) acts as a cellular receptor for measles virus. J Virol 1993; 67(10):6025-6032.
47. Nussbaum O, Broder CC, Moss B et al. Functional and structural interactions between measles virus hemagglutinin and CD46. J Virol 1995; 69(6):3341-3349.
48. Tatsuo H, Ono N, Tanaka K et al. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406(6798):893-897.
49. Tatsuo H, Ono N, Yanagi Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J Virol 2001; 75(13):5842-5850.
50. Baron MD. Wild-type Rinderpest virus uses SLAM (CD150) as its receptor. J Gen Virol 2005; 86(Pt 6):1753-1757.
51. Galbraith SE, Tiwari A, Baron MD et al. Morbillivirus downregulation of CD46. J Virol 1998; 72(12):10292-10297.
52. Welstead GG, Hsu EC, Iorio C et al. Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein. J Virol 2004; 78(18):9666-9674.
53. Masse N, Ainouze M, Neel B et al. Measles virus (MV) hemagglutinin: evidence that attachment sites for MV receptors SLAM and CD46 overlap on the globular head. J Virol 2004; 78(17):9051-9063.
54. Vongpunsawad S, Oezgun N, Braun W et al. Selectively receptor-blind measles viruses: Identification of residues necessary for SLAM- or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 2004; 78(1):302-313.
55. Leonard VH, Sinn PL, Hodge G et al. Measles virus blind to its epithelial cell receptor remains virulent in rhesus monkeys but cannot cross the airway epithelium and is not shed. J Clin Invest 2008; 118(7):2448-2458.
56. Tahara M, Takeda M, Shirogane Y et al. Measles virus infects both polarized epithelial and immune cells by using distinctive receptor-binding sites on its hemagglutinin. J Virol 2008; 82(9):4630-4637.
57. Noyce RS, Bondre DG, Ha MN et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 2011; 7(8):e1002240.
58. Muhlebach MD, Mateo M, Sinn PL et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011; 480(7378):530-533.
59. Noyce RS, Richardson CD. Nectin 4 is the epithelial cell receptor for measles virus. Trends Microbiol 2012; 20(9):429-439.
60. Zhang X, Lu G, Qi J et al. Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4. Nat Struct Mol Biol 2012.
61. Santiago C, Celma ML, Stehle T et al. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol 2010; 17(1):124-129.
62. Hashiguchi T, Ose T, Kubota M et al. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol 2011; 18(2):135-141.
63. Bossart KN, Wang LF, Flora MN et al. Membrane fusion tropism and heterotypic functional activities of the Nipah virus and Hendra virus envelope glycoproteins. J Virol 2002; 76(22):11186-11198.
64. Bossart KN, Wang LF, Eaton BT et al. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology 2001; 290(1):121-135.
65. Eaton BT, Wright PJ, Wang LF et al. Henipaviruses: recent observations on regulation of transcription and the nature of the cell receptor. Arch Virol Suppl 2004(18):122-131.
66. Bonaparte MI, Dimitrov AS, Bossart KN et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci USA 2005; 102(30):10652-10657.
67. Negrete OA, Levroney EL, Aguilar HC et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature 2005; 436(7049):401-405.
68. Negrete OA, Wolf MC, Aguilar HC et al. Two key residues in EphrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog 2006; 2(2):e7.
69. Bishop KA, Stantchev TS, Hickey AC et al. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol 2007; 81(11):5893-5901.
70. Bossart KN, McEachern JA, Hickey AC et al. Neutralization assays for differential henipavirus serology using Bio-Plex Protein Array Systems. J Virol Methods 2007; 142(1-2):29-40.
71. Bowden TA, Crispin M, Harvey DJ et al. Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol 2010; 84(12):6208-6217.
72. Bowden TA, Crispin M, Harvey DJ et al. Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design. J Virol 2008; 82(23):11628-11636.
73. Xu K, Chan YP, Rajashankar KR et al. New insights into the Hendra virus attachment and entry process from structures of the virus G glycoprotein and its complex with Ephrin-B2. PLoS One 2012; 7(11):e48742.
74. Collins PL, Crowe J, J.E. Respiratory Syncytial Virus and Metapneumovirus. In: Knipe DM, Howley PM ed. Fields Virology, 5 ed. Philadelphia: Lippincott Williams & Wilkins, 2007:1601-1646.
75. Harris J, Werling D. Binding and entry of respiratory syncytial virus into host cells and initiation of the innate immune response. Cell Microbiol 2003; 5(10):671-680.
76. van den Hoogen BG, Bestebroer TM, Osterhaus AD et al. Analysis of the genomic sequence of a human metapneumovirus. Virology 2002; 295(1):119-132.
77. Teng MN, Whitehead SS, Collins PL. Contribution of the respiratory syncytial virus G glycoprotein and its secreted and membrane-bound forms to virus replication in vitro and in vivo. Virology 2001; 289(2):283-296.
78. Karron RA, Buonagurio DA, Georgiu AF et al. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci USA 1997; 94(25):13961-13966.
79. Karron RA, Thumar B, Schappell E et al. Evaluation of two chimeric bovine-human parainfluenza virus type 3 vaccines in infants and young children. Vaccine 2012; 30(26):3975-3981.
80. Karger A, Schmidt U, Buchholz UJ. Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin. J Gen Virol 2001; 82(Pt 3):631-640.
81. Techaarpornkul S, Barretto N, Peeples ME. Functional analysis of recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and/or attachment glycoprotein gene. J Virol 2001; 75(15):6825-6834.
82. Teng MN, Collins PL. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J Virol 1998; 72(7):5707-5716.
83. Feldman SA, Hendry RM, Beeler JA. Identification of a linear heparin binding domain for human respiratory syncytial virus attachment glycoprotein G. J Virol 1999; 73(8):6610-6617.
84. Cantin C, Holguera J, Ferreira L et al. Newcastle disease virus may enter cells by caveolae-mediated endocytosis. J Gen Virol 2007; 88(Pt 2):559-569.
85. Kolokoltsov AA, Deniger D, Fleming EH et al. Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol 2007; 81(14):7786-7800.
86. Biacchesi S, Skiadopoulos MH, Yang L et al. Recombinant human Metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J Virol 2004; 78(23):12877-12887.
87. Biacchesi S, Pham QN, Skiadopoulos MH et al. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol 2005; 79(19):12608-12613.
88. Chang A, Masante C, Buchholz UJ et al. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol 2012; 86(6):3230-3243.
89. Cseke G, Maginnis MS, Cox RG et al. Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc Natl Acad Sci USA 2009; 106(5):1566-1571.
90. Schowalter RM, Smith SE, Dutch RE. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J Virol 2006; 80(22):10931-10941.
91. Schowalter RM, Chang A, Robach JG et al. Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J Virol 2009; 83(3):1511-1522.
92. Jack PJM, Boyle DB, Eaton BT et al. The complete genome sequence of J-virus reveals a unique genome structure in the family Paramyxoviridae. J Virol 2005; In Press.
93. Jack PJ, Anderson DE, Bossart KN et al. Expression of novel genes encoded by the paramyxovirus J virus. J Gen Virol 2008; 89(Pt 6):1434-1441.
94. Paterson RG, Johnson ML, Lamb RA. Paramyxovirus fusion (F) protein and hemagglutinin-neuraminidase (HN) protein interactions: intracellular retention of F and HN does not affect transport of the homotypic HN or F protein. Virology 1997; 237(1):1-9.
95. Chan DC, Fass D, Berger JM et al. Core structure of gp41 from the HIV envelope glycoprotein. Cell 1997; 89(2):263-273.
96. Fass D, Harrison SC, Kim PS. Retrovirus envelope domain at 1.7 angstrom resolution. Nat Struct Biol 1996; 3(5):465-469.
97. Wilson IA, Skehel JJ, Wiley DC. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 1981; 289(5796):366-373.
98. Chen L, Colman PM, Cosgrove LJ et al. Cloning, expression, and crystallization of the fusion protein of Newcastle disease virus. Virology 2001; 290(2):290-299.
99. Yin HS, Paterson RG, Wen X et al. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci USA 2005.
100. Yin HS, Wen X, Paterson RG et al. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature 2006; 439(7072):38-44.
101. Cao J, Bergeron L, Helseth E et al. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein. J Virol 1993; 67:2747-2755.
102. Hernandez LD, Hoffman LR, Wolfsberg TG et al. Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol 1996; 12:627-661.
103. Lescar J, Roussel A, Wien MW et al. The Fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH. Cell 2001; 105(1):137-148.
104. White JM, Delos SE, Brecher M et al. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol 2008; 43(3):189-219.
105. Scheid A, Choppin PW. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 1974; 57(2):475-490.
106. Klenk HD, Garten W. Host cell proteases controlling virus pathogenicity. Trends Microbiol 1994; 2(2):39-43.
107. Gotoh B, Yamauchi F, Ogasawara T et al. Isolation of factor Xa from chick embryo as the amniotic endoprotease responsible for paramyxovirus activation. FEBS Lett 1992; 296(3):274-278.
108. Nagai Y, Klenk HD. Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. Virology 1977; 77(1):125-134.
109. Pager CT, Dutch RE. Cathepsin L is involved in proteolytic processing of the hendra virus fusion protein. J Virol 2005; 79(20):12714-12720.
110. Pager CT, Craft WW, Jr., Patch J et al. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 2006; 346(2):251-257.
111. Baker KA, Dutch RE, Lamb RA et al. Structural basis for paramyxovirus-mediated membrane fusion. Mol Cell 1999; 3(3):309-319.
112. Hunter E. Viral entry and receptors. In: Coffin SH, Hughes SH, and Varmus HE, eds. Retroviruses. New York: Cold Spring Harbor Laboratory Press, 1997:71-119.
113. Novick SL, Hoekstra D. Membrane penetration of Sendai virus glycoproteins during the early stages of fusion with liposomes as determined by hydrophobic photoaffinity labeling. Proc Natl Acad Sci USA 1988; 85(20):7433-7437.
114. Dutch RE, Jardetzky TS, Lamb RA. Virus membrane fusion proteins: biological machines that undergo a metamorphosis. Biosci Rep 2000; 20(6):597-612.
115. Singh M, Berger B, Kim PS. LearnCoil-VMF: computational evidence for coiled-coil-like motifs in many viral membrane-fusion proteins. J Mol Biol 1999; 290(5):1031-1041.
116. Hughson FM. Enveloped viruses: a common mode of membrane fusion? Curr Biol 1997; 7(9):R565-569.
117. Plemper RK, Compans RW. Mutations in the putative HR-C region of the measles virus F2 glycoprotein modulate syncytium formation. J Virol 2003; 77(7):4181-4190.
118. Wild CT, Shugars DC, Greenwell TK et al. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. Proc Natl Acad Sci USA 1994; 91(21):9770-9774.
119. Jiang S, Lin K, Strick N et al. HIV-1 inhibition by a peptide. Nature 1993; 365:113.
120. Lambert DM, Barney S, Lambert AL et al. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci USA 1996; 93(5):2186-2191.
121. Joshi SB, Dutch RE, Lamb RA. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology 1998; 248(1):20-34.
122. Wild TF, Buckland R. Inhibition of measles virus infection and fusion with peptides corresponding to the leucine zipper region of the fusion protein. J Gen Virol 1997; 78(Pt 1):107-111.
123. Young JK, Li D, Abramowitz MC et al. Interaction of peptides with sequences from the Newcastle disease virus fusion protein heptad repeat regions. J Virol 1999; 73(7):5945-5956.
124. Young JK, Hicks RP, Wright GE et al. Analysis of a peptide inhibitor of paramyxovirus (NDV) fusion using biological assays, NMR, and molecular modeling. Virology 1997; 238(2):291-304.
125. Rapaport D, Ovadia M, Shai Y. A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses. Embo J 1995; 14(22):5524-5531.
126. Bossart KN, Mungall BA, Crameri G et al. Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein. Virol J 2005; 2:57.
127. Dutch RE, Hagglund RN, Nagel MA et al. Paramyxovirus fusion (F) protein: a conformational change on cleavage activation. Virology 2001; 281(1):138-150.
128. Zhao X, Singh M, Malashkevich VN et al. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci USA 2000; 97(26):14172-14177.
129. Zhu J, Zhang CW, Qi Y et al. The fusion protein core of measles virus forms stable coiled-coil trimer. Biochem Biophys Res Commun 2002; 299(5):897-902.
130. Liu Y, Xu Y, Zhu J et al. Crystallization and preliminary X-ray diffraction analysis of central structure domains from mumps virus F protein. Acta Crystallograph Sect F Struct Biol Cryst Commun 2005; 61(Pt 9):855-857.
131. Xu Y, Lou Z, Liu Y et al. Crystallization and preliminary crystallographic analysis of the fusion core from two new zoonotic paramyxoviruses, Nipah virus and Hendra virus. Acta Crystallogr D Biol Crystallogr 2004; 60(Pt 6):1161-1164.
132. Chen L, Gorman JJ, McKimm-Breschkin J et al. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure (Camb) 2001; 9(3):255-266.
133. Lamb RA, Paterson RG, Jardetzky TS. Paramyxovirus membrane fusion: Lessons from the F and HN atomic structures. Virology 2006; 344(1):30-37.
134. Russell CJ, Kantor KL, Jardetzky TS et al. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J Cell Biol 2003; 163(2):363-374.
135. Harbury PB, Kim PS, Alber T. Crystal structure of an isoleucine-zipper trimer. Nature 1994; 371(6492):80-83.
136. Welch BD, Liu Y, Kors CA et al. Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc Natl Acad Sci USA 2012; 109(41):16672-16677.
137. Chan YP, Lu M, Dutta S et al. Biochemical, conformational, and immunogenic analysis of soluble trimeric forms of henipavirus fusion glycoproteins. J Virol 2012; 86(21):11457-11471.
138. Russell CJ, Jardetzky TS, Lamb RA. Membrane fusion machines of paramyxoviruses: capture of intermediates of fusion. Embo J 2001; 20(15):4024-4034.
139. Steinhauer DA, Plemper RK. Structure of the primed paramyxovirus fusion protein. Proc Natl Acad Sci USA 2012; 109(41):16404-16405.
140. Aguilar HC, Matreyek KA, Choi DY et al. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling. J Virol 2007; 81(9):4520-4532.
141. Paterson RG, Russell CJ, Lamb RA. Fusion protein of the paramyxovirus SV5: destabilizing and stabilizing mutants of fusion activation. Virology 2000; 270(1):17-30.
142. Waning DL, Russell CJ, Jardetzky TS et al. Activation of a paramyxovirus fusion protein is modulated by inside-out signaling from the cytoplasmic tail. Proc Natl Acad Sci USA 2004; 101(25):9217-9222.
143. Smith EC, Culler MR, Hellman LM et al. Beyond anchoring: the expanding role of the hendra virus fusion protein transmembrane domain in protein folding, stability, and function. J Virol 2012; 86(6):3003-3013.
144. Skehel JJ, Wiley DC. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 2000; 69:531-569.
145. Hu XL, Ray R, Compans RW. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses [published erratum appears in J Virol 1992 Aug;66(8):5176]. J Virol 1992; 66(3):1528-1534.
146. Bagai S, Lamb RA. Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol 1995; 69(11):6712-6719.
147. Bousse T, Takimoto T, Gorman WL et al. Regions on the hemagglutinin-neuraminidase proteins of human parainfluenza virus type-1 and Sendai virus important for membrane fusion. Virology 1994; 204(2):506-514.
148. Deng R, Wang Z, Mirza AM et al. Localization of a domain on the paramyxovirus attachment protein required for the promotion of cellular fusion by its homologous fusion protein spike. Virology 1995; 209(2):457-469.
149. Tanabayashi K, Compans RW. Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol 1996; 70(9):6112-6118.
150. Tsurudome M, Kawano M, Yuasa T et al. Identification of regions on the hemagglutinin-neuraminidase protein of human parainfluenza virus type 2 important for promoting cell fusion. Virology 1995; 213(1):190-203.
151. Melanson VR, Iorio RM. Amino acid substitutions in the F-specific domain in the stalk of the newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J Virol 2004; 78(23):13053-13061.
152. Melanson VR, Iorio RM. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J Virol 2006; 80(2):623-633.
153. Lamb RA. Paramyxovirus fusion: A hypothesis for changes. Virology 1993; 197:1-11.
154. McGinnes LW, Gravel K, Morrison TG. Newcastle disease virus HN protein alters the conformation of the F protein at cell surfaces. J Virol 2002; 76(24):12622-12633.
155. Morrison T, McQuain C, McGinnes L. Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol 1991; 65(2):813-822.
156. Connolly SA, Leser GP, Jardetzky TS et al. Bimolecular complementation of paramyxovirus fusion and hemagglutinin-neuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J Virol 2009; 83(21):10857-10868.
157. Yao Q, Hu X, Compans RW. Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol 1997; 71(1):650-656.
158. McGinnes LW, Morrison TG. Inhibition of receptor binding stabilizes newcastle disease virus HN and F protein-containing complexes. J Virol 2006; 80(6):2894-2903.
159. Li J, Quinlan E, Mirza A et al. Mutated form of the Newcastle disease virus hemagglutinin-neuraminidase interacts with the homologous fusion protein despite deficiencies in both receptor recognition and fusion promotion. J Virol 2004; 78(10):5299-5310.
160. Deng R, Wang Z, Mahon PJ et al. Mutations in the Newcastle disease virus hemagglutinin-neuraminidase protein that interfere with its ability to interact with the homologous F protein in the promotion of fusion. Virology 1999; 253(1):43-54.
161. Plemper RK, Hammond AL, Cattaneo R. Measles virus envelope glycoproteins hetero-oligomerize in the endoplasmic reticulum. J Biol Chem 2001; 276(47):44239-44246.
162. Plemper RK, Hammond AL, Gerlier D et al. Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol 2002; 76(10):5051-5061.
163. Corey EA, Iorio RM. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. J Virol 2007; 81(18):9900-9910.
164. Corey EA, Iorio RM. Measles virus attachment proteins with impaired ability to bind CD46 interact more efficiently with the homologous fusion protein. Virology 2009; 383(1):1-5.
165. Aguilar HC, Matreyek KA, Filone CM et al. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol 2006; 80(10):4878-4889.
166. Aguilar HC, Ataman ZA, Aspericueta V et al. A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F). J Biol Chem 2009; 284(3):1628-1635.
167. Whitman SD, Smith EC, Dutch RE. Differential rates of protein folding and cellular trafficking for the Hendra virus F and G proteins: implications for F-G complex formation. J Virol 2009; 83(17):8998-9001.
168. Stone-Hulslander J, Morrison TG. Detection of an interaction between the HN and F proteins in Newcastle disease virus-infected cells. J Virol 1997; 71(9):6287-6295.
169. Tong S, Compans RW. Alternative mechanisms of interaction between homotypic and heterotypic parainfluenza virus HN and F proteins. J Gen Virol 1999; 80(Pt 1):107-115.
170. Whitman SD, Dutch RE. Surface density of the Hendra G protein modulates Hendra F protein-promoted membrane fusion: role for Hendra G protein trafficking and degradation. Virology 2007; 363(2):419-429.
171. Lee B, Ataman ZA. Modes of paramyxovirus fusion: a Henipavirus perspective. Trends Microbiol 2011; 19(8):389-399.
172. Chang A, Dutch RE. Paramyxovirus fusion and entry: multiple paths to a common end. Viruses 2012; 4(4):613-636.
173. Zhu Q, Biering SB, Mirza AM et al. Individual N-glycans added at intervals along the stalk of the Nipah virus G protein prevent fusion, but do not block the interaction with the homologous F protein. J Virol 2013; Jan 2. [Epub ahead of print]
174. Paal T, Brindley MA, St Clair C et al. Probing the spatial organization of measles virus fusion complexes. J Virol 2009; 83(20):10480-10493.
175. Brindley MA, Takeda M, Plattet P et al. Triggering the measles virus membrane fusion machinery. Proc Natl Acad Sci USA 2012; 109(44):E3018-3027.
176. Ader N, Brindley M, Avila M et al. Mechanism for active membrane fusion triggering by morbillivirus attachment protein. J Virol 2013; 87(1):314-326.
177. Porotto M, Devito I, Palmer SG et al. Spring-loaded model revisited: paramyxovirus fusion requires engagement of a receptor binding protein beyond initial triggering of the fusion protein. J Virol 2011; 85(24):12867-12880.
178. Porotto M, Palmer SG, Palermo LM et al. Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry. J Biol Chem 2012; 287(1):778-793.
179. Sergel T, McGinnes LW, Peeples ME et al. The attachment function of the Newcastle disease virus hemagglutinin-neuraminidase protein can be separated from fusion promotion by mutation. Virology 1993; 193(2):717-726.
180. Takimoto T, Taylor GL, Crennell SJ et al. Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. Virology 2000; 270(1):208-214.
181. Takimoto T, Taylor GL, Connaris HC et al. Role of the hemagglutinin-neuraminidase protein in the mechanism of paramyxovirus-cell membrane fusion. J Virol 2002; 76(24):13028-13033.
182. Mishin VP, Watanabe M, Taylor G et al. N-linked glycan at residue 523 of human parainfluenza virus type 3 hemagglutinin-neuraminidase masks a second receptor-binding site. J Virol 2010; 84(6):3094-3100.
183. Bousse T, Takimoto T. Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein. J Virol 2006; 80(18):9009-9016.
184. Porotto M, Fornabaio M, Kellogg GE et al. A second receptor binding site on human parainfluenza virus type 3 hemagglutinin-neuraminidase contributes to activation of the fusion mechanism. J Virol 2007; 81(7):3216-3228.
185. Alymova IV, Portner A, Mishin VP et al. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Glycobiology 2012; 22(2):174-180.
186. Bousse TL, Taylor G, Krishnamurthy S et al. Biological significance of the second receptor binding site of Newcastle disease virus hemagglutinin- neuraminidase protein. J Virol 2004; 78(23):13351-13355.
187. Mahon PJ, Mirza AM, Iorio RM. Role of the two sialic acid binding sites on the newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion. J Virol 2011; 85(22):12079-12082.
188. Porotto M, Salah Z, DeVito I et al. The second receptor binding site of the globular head of the Newcastle disease virus hemagglutinin-neuraminidase activates the stalk of multiple paramyxovirus receptor binding proteins to trigger fusion. J Virol 2012; 86(10):5730-5741.
189. Mahon PJ, Mirza AM, Musich TA et al. Engineered intermonomeric disulfide bonds in the globular domain of Newcastle disease virus hemagglutinin- neuraminidase protein: implications for the mechanism of fusion promotion. J Virol 2008; 82(21):10386-10396.
190. Navaratnarajah CK, Oezguen N, Rupp L et al. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol 2011; 18(2):128-134.
191. Lee JK, Prussia A, Paal T et al. Functional interaction between paramyxovirus fusion and attachment proteins. J Biol Chem 2008; 283(24):16561-16572.
192. Plemper RK, Brindley MA, Iorio RM. Structural and mechanistic studies of measles virus illuminate paramyxovirus entry. PLoS Pathog 2011; 7(6):e1002058.
193. Ader N, Brindley MA, Avila M et al. Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger F protein refolding for membrane fusion. J Biol Chem 2012; 287(20):16324-16334.
194. Navaratnarajah CK, Negi S, Braun W et al. Membrane fusion triggering: three modules with different structure and function in the upper half of the measles virus attachment protein stalk. J Biol Chem 2012.
195. Apte-Sengupta S, Negi S, Leonard VH et al. Base of the measles virus fusion trimer head receives the signal that triggers membrane fusion. J Biol Chem 2012; 287(39):33026-33035.
196. Bose S, Zokarkar A, Welch BD et al. Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering. Proc Natl Acad Sci USA 2012; 109(39):E2625-2634.
197. Bishop KA, Hickey AC, Khetawat D et al. Residues in the stalk domain of the hendra virus g glycoprotein modulate conformational changes associated with receptor binding. J Virol 2008; 82(22):11398-11409.